Section Arrow
Quote
IGC.NYSE-M
- IGC Pharma
Quotes are at least 15-min delayed:2024/05/20 08:36 EDT
Last
 0.56
-0.0358 (-6.01%)
Day High 
0.62 
Prev. Close
0.5958 
1-M High
0.65 
Volume 
823.26K 
Bid
0.56
Ask
0.5799
Day Low
0.53 
Open
0.61 
1-M Low
0.413 
Market Cap 
39.81M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 0.53 
20-SMA 0.5 
50-SMA 0.47 
52-W High 0.9099 
52-W Low 0.2501 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.26/-0.16
Enterprise Value
40.16M
Balance Sheet
Book Value Per Share
0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
911.00K
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals0.1186-0.0014-1.17%-- 
SCPXScorpius Holdings0.1035+0.0034+3.40%-- 
JAGXJaguar Health0.2585-0.0282-9.84%-- 
DNAGinkgo Bioworks Holdings0.8056-0.0334-3.98%-- 
ONCOOnconetix0.156+0.015+10.64%-- 
Quotes are at least 15-min delayed：2024/05/20 08:36 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.